No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
BLTE Belite Bio
- 38.000
- +0.730+1.96%
Close Apr 25 16:00 ET
1.13BMarket Cap-31932P/E (TTM)
38.490High36.010Low16.04KVolume36.010Open37.270Pre Close599.22KTurnover0.14%Turnover RatioLossP/E (Static)29.75MShares48.60052wk High12.50P/B425.99MFloat Cap11.00052wk Low--Dividend TTM11.21MShs Float48.600Historical High--Div YieldTTM6.65%Amplitude8.800Historical Low37.369Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Belite Bio Unveils Plan to Offer 651,380 American Depository Shares
Belite Bio (BLTE) said late Thursday it is planning to sell up to 651,380 American depositary shares at $38.38 per ADS in a registered direct offering. The company also plans to sell warrants to purch
Belite Bio Prices $25M Direct Offering
Reported Earlier, Belite Bio Secures $25M In Registered Direct Offering With Institutional Investors
Belite Bio entered into a securities purchase agreement with an institutional investor, for the purchase and sale of up to an aggregate of 651,380 American Depositary Shares of the Company ("ADSs"), e
Express News | Belite Bio Announces $25 Million Registered Direct Offering
Belite Bio Is Maintained at Buy by HC Wainwright & Co.
Belite Bio Is Maintained at Buy by HC Wainwright & Co.
Express News | HC Wainwright & Co. Maintains Buy on Belite Bio, Maintains $59 Price Target
Comments
5/31 TOP WATCH ⚡️⚡️
Follow for best watchlist daily 🎁
$AbbVie(ABBV.US$$Aclarion(ACON.US$$Amgen(AMGN.US$$Atento(ATTO.US$$Broadcom(AVGO.US$$Belite Bio(BLTE.US$$Corvus Pharmaceuticals(CRVS.US$$CXApp(CXAI.US$$Equitrans Midstream(ETRN.US$$H World Group(HTHT.US$$Iovance Biotherapeutics(IOVA.US$$JD.com(JD.US$$Lexicon Pharmaceuticals(LXRX.US$$LL Flooring(LL.US$$Merck & Co(MRK.US$$Nutrien(NTR.US$
$AbbVie(ABBV.US$$Aclarion(ACON.US$$Amgen(AMGN.US$$Atento(ATTO.US$$Broadcom(AVGO.US$$Belite Bio(BLTE.US$$Corvus Pharmaceuticals(CRVS.US$$CXApp(CXAI.US$$Equitrans Midstream(ETRN.US$$H World Group(HTHT.US$$Iovance Biotherapeutics(IOVA.US$$JD.com(JD.US$$Lexicon Pharmaceuticals(LXRX.US$$LL Flooring(LL.US$$Merck & Co(MRK.US$$Nutrien(NTR.US$
2
ColumnsToday's pre-market stock movers: NFLX, NVAX, ASML, BBWI and more
Gainers:
In reaction to earnings/guidance:
• $Omnicom Group(OMC.US$ +6.8% (Omnicom reports Q2 EPS $1.68, consensus $1.58)
• $Netflix(NFLX.US$+6.3% (Netflix executives said they expect 1 million new subscribers to join in the third quarter, with revenue forecast to grow to $7.84 billion from $7.48 billion a year ago)
• $Fulton Financial(FULT.US$ +4.3% (Fulton Financial reports Q2 EPS 42c, consensus 37c)
• $Abbott Laboratories(ABT.US$ +0.6% (Ab...
In reaction to earnings/guidance:
• $Omnicom Group(OMC.US$ +6.8% (Omnicom reports Q2 EPS $1.68, consensus $1.58)
• $Netflix(NFLX.US$+6.3% (Netflix executives said they expect 1 million new subscribers to join in the third quarter, with revenue forecast to grow to $7.84 billion from $7.48 billion a year ago)
• $Fulton Financial(FULT.US$ +4.3% (Fulton Financial reports Q2 EPS 42c, consensus 37c)
• $Abbott Laboratories(ABT.US$ +0.6% (Ab...
19
2
ColumnsTop upgrades and downgrades on 7/1: CMCSA, FDX, XPEV, HOG and more
Upgrades
• $Coupang(CPNG.US$ : Credit Suisse Upgrades to Outperform from Neutral - PT $19 (from $28)
• $First Republic Bank(FRC.US$ : Atlantic Equities Upgrades to Overweight from Neutral - PT $188 (from $210)
• $Sitio Royalties(STR.US$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $43 (from $36)
Downgrades
• $Duck Creek Technologies(DCT.US$ : JMP Securities Downgrades to Market Perform from Market Outperform
•...
• $Coupang(CPNG.US$ : Credit Suisse Upgrades to Outperform from Neutral - PT $19 (from $28)
• $First Republic Bank(FRC.US$ : Atlantic Equities Upgrades to Overweight from Neutral - PT $188 (from $210)
• $Sitio Royalties(STR.US$ : RBC Capital Upgrades to Outperform from Sector Perform - PT $43 (from $36)
Downgrades
• $Duck Creek Technologies(DCT.US$ : JMP Securities Downgrades to Market Perform from Market Outperform
•...
14
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg